血栓性
因素五莱顿
医学
凝血酶原G20210A
高同型半胱氨酸血症
蛋白质S
蛋白质S缺乏症
活化蛋白C抗性
因子V
蛋白质C
蛋白质C缺乏
怀孕
内科学
产科
同型半胱氨酸
血栓形成
静脉血栓形成
遗传学
生物
作者
Priyanka Mishra,Kanwaljeet Singh,Seema Tyagi,Richa Juneja,Manoranjan Mahapatra
标识
DOI:10.4103/ijpm.ijpm_1317_20
摘要
Objectives: The spectrum of thrombophilia in women with recurrent pregnancy loss (RPL) is different in Indian ethnicity as reported by few studies. We aimed to study the prevalence of thrombophilia in RPL patients referred to hematology department of a tertiary centre. Material and Methods: This is an observational study of 112 RPL patients with no apparent cause after extensive workup for non-hematological causes. The investigations performed were routine coagulogram, APLA workup, plasma homocysteine, MTHFRC677T polymorphisms, Protein C, free Protein S, Anti-thrombin III levels, test for Activated Protein C resistance (APC-R), Factor V Leiden and Prothrombin gene G20210A mutation. Results: Of 112 patients, at least one thrombophilia was identified in 70.5% and combined thrombophilia in 12.5% patients. Hyperhomocysteinemia (30.4%) and APLA (25.9%) were the commonest thrombophilia whereas anticoagulant defects were seen in 12.5% of the population. Protein C deficiency (5.35%) was the commonest anticoagulant defect followed by APCR (3.6%). Mutational analysis revealed MTHFRC677T polymorphism in 20.5% whereas Factor V Leiden heterozygous in 1.8% patients. None of the patients had homozygous Factor V Leiden or Prothrombin gene G20210A mutation. Hyperhomocysteinemia, MTHFRC677T and Protein C deficiency were more associated with early pregnancy losses whereas Protein S deficiency, Factor V Leiden and APLA caused both early and late losses. Patients with greater number of losses were positive for homozygous MTHFRC677T, factor V Leiden and APLA. Conclusion: The approach to investigating Indian women with RPL should be based on the prevalence of thrombophilia which is unique to Indian ethnicity.
科研通智能强力驱动
Strongly Powered by AbleSci AI